Cargando…
Long-term results of St. Jude Total Therapy studies 11, 12, 13A, 13B and 14 for childhood acute lymphoblastic leukemia
We analyzed the long-term outcome of 1011 patients treated in five successive clinical trials (Total Therapy Studies 11, 12, 13A, 13B and 14) between 1984 and 1999. The event-free survival improved significantly (p=0.003) from the first two trials conducted in the 1980s to the three more recent tria...
Autores principales: | Pui, C-H, Pei, D, Sandlund, JT, Ribeiro, RC, Rubnitz, JE, Raimondi, SC, Onciu, M, Campana, D, Kun, LE, Jeha, S, Cheng, C, Howard, SC, Metzger, ML, Bhojwani, D, Downing, JR, Evans, WE, Relling, MV |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2820159/ https://www.ncbi.nlm.nih.gov/pubmed/20010620 http://dx.doi.org/10.1038/leu.2009.252 |
Ejemplares similares
-
A Revised Definition for Cure of Childhood Acute Lymphoblastic Leukemia
por: Pui, CH, et al.
Publicado: (2014) -
Clofarabine treatment of KMT2Ar infantile patients with acute lymphoblastic leukemia in St. Jude Total Therapy Study 16
por: Gruber, Tanja A., et al.
Publicado: (2022) -
Combination of Cladribine and Cytarabine is Effective for Childhood Acute Myeloid Leukemia: Results of the St. Jude AML97 Trial
por: Rubnitz, Jeffrey E., et al.
Publicado: (2009) -
Clinical Impact of Minimal Residual Disease in Children with Different Subtypes of Acute Lymphoblastic Leukemia Treated with Response-Adapted Therapy
por: Pui, Ching-Hon, et al.
Publicado: (2016) -
Jude the obscure
por: Hardy, Thomas, 1840-1928
Publicado: (1961)